Keratinocyte-specific deletion of the receptor rage modulates the kinetics of skin inflammation in vivo

Journal of Investigative Dermatology

Volumn 133, Issue 10, 2013, Pages 2400-2406

  Leibold, Julia S ^a,d   Riehl, Astrid ^a   Hettinger, Jan ^b   Durben, Michael ^c   Hess, Jochen ^a,d   Angel, Peter ^a  

^a GERMAN CANCER RESEARCH CENTER   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DERMATITIS; EPIDERMIS CELL; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENETIC ANALYSIS; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; KERATINOCYTE; KINETICS; LASER MICRODISSECTION; MODULATION; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; STROMA CELL;

EID: 84884286043     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.185     Document Type: Article

References (30)

1. Alexiou P, Chatzopoulou M, Pegklidou K et al. (2010) RAGE: a multi-ligand receptor unveiling novel insights in health and disease. Curr Med Chem 17: 2232-52
2. Arumugam T, Ramachandran V, Gomez SB et al. (2012) S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis. Clin Cancer Res 18: 4356-64
3. Bianchi R, Giambanco I, Donato R (2010) S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha. Neurobiol Aging 31: 665-77
4. Bopp C, Bierhaus A, Hofer S et al. (2008) Bench-to-bedside review: the inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis. Crit Care 12:201
5. Chavakis T, Bierhaus A, Nawroth PP (2004) RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect 6: 1219-25
6. Chen Y, Yan SS, Colgan J et al. (2004) Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products. J Immunol 173: 1399-405
7. Frommhold D, Kamphues A, Dannenberg S et al. (2011) RAGE and ICAM-1 differentially control leukocyte recruitment during acute inflammation in a stimulus-dependent manner. BMC Immunol 12:56
8. Gebhardt C, Riehl A, Durchdewald M et al. (2008) RAGE signaling sustains inflammation and promotes tumor development. J Exp Med 205: 275-85
9. Hessian PA, Edgeworth J, Hogg N (1993) MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J Leukoc Biol 53: 197-204
10. Hofmann MA, Drury S, Fu C et al. (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97: 889-901
11. Huelsken J, Vogel R, Erdmann B et al. (2001) Beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 105: 533-45
12. Liang YJ, Jian JH, Liu YC et al. (2010) Advanced glycation end productsinduced apoptosis attenuated by PPARdelta activation and epigallocatechin gallate through NF-kappaB pathway in human embryonic kidney cells and human mesangial cells. Diabetes Metab Res Rev 26: 406-16
13. Liliensiek B, Weigand MA, Bierhaus A et al. (2004) Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 113: 1641-50
14. Mansbridge J, Knapp M (1987) Effects of filaggrin breakdown products on the growth and maturation of keratinocytes. Arch Dermatol Res 279: 465-9
15. McPhillips K, Janssen WJ, Ghosh M et al. (2007) TNF-alpha inhibits macrophage clearance of apoptotic cells via cytosolic phospholipase A2 and oxidant-dependent mechanisms. J Immunol 178: 8117-26
16. Miyata T, Hori O, Zhang J et al. (1996) The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGEbeta2microglobulin with human mononuclear phagocytes via an oxidantsensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis. J Clin Invest 98: 1088-94
17. Molloy CJ, Laskin JD (1987) Specific alterations in keratin biosynthesis in mouse epidermis in vivo and in explant culture following a single exposure to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 47: 4674-80
18. Moore RJ, Owens DM, Stamp G et al. (1999) Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med 5: 828-31
19. Mukherjee TK, Mukhopadhyay S, Hoidal JR (2005) The role of reactive oxygen species in TNFalpha-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells. Biochim Biophys Acta 1744: 213-23
20. Ramasamy R, Yan SF, Schmidt AM (2011) Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Ann N Y Acad Sci 1243: 88-102
21. Riehl A, Bauer T, Brors B et al. (2010) Identification of the Rage-dependent gene regulatory network in a mouse model of skin inflammation. BMC Genomics 11:537
22. Rothnagel JA, Seki T, Ogo M et al. (1999) The mouse keratin 6 isoforms are differentially expressed in the hair follicle, footpad, tongue and activated epidermis. Differentiation 65: 119-30
23. Schmidt AM, Yan SD, Yan SF et al. (2001) The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108: 949-55
24. Soehnlein O, Lindbom L (2010) Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 10: 427-39
25. Tanaka N, Yonekura H, Yamagishi S et al. (2000) The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem 275: 25781-90
26. Turovskaya O, Foell D, Sinha P et al. (2008) RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis 29: 2035-43
27. Vassalli P (1992) The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10: 411-52
28. Wolf R, Mascia F, Dharamsi A et al. (2010) Gene from a psoriasis susceptibility locus primes the skin for inflammation. Sci Transl Med 2:61ra90
29. Wrone-Smith T, Nickoloff BJ (1996) Dermal injection of immunocytes induces psoriasis. J Clin Invest 98: 1878-87
30. Yan SD, Schmidt AM, Anderson GM et al. (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269: 9889-97